To Assess the Efficacy and Safety of Various Anti-heliminthics against Ascariasis Lumbricoides among a Study Population in North India
Zaffar A. Kawoosa, G. Javid, G. Yattoo, G. M. Gulzar, J. Sodhi, Altaf Shah, M. Khan, S. Hamid
{"title":"To Assess the Efficacy and Safety of Various Anti-heliminthics against Ascariasis Lumbricoides among a Study Population in North India","authors":"Zaffar A. Kawoosa, G. Javid, G. Yattoo, G. M. Gulzar, J. Sodhi, Altaf Shah, M. Khan, S. Hamid","doi":"10.5530/OGH.2018.7.1.5","DOIUrl":null,"url":null,"abstract":"Copyright © 2018 Phcog.Net. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license. Cite this article: Kawoosa Z, Javid G, Yattoo GN, Gulzar GM, Sodhi JS, Shah AH, Khan M, Hamid S. To Assess the Efficacy and Safety of Various Anti-heliminthics against Ascariasis Lumbricoides among a Study Population in North India. OGH Reports. 2018;7(1):25-34. ABSTRACT Introduction: More than 24% of the world’s population, are infected with soil-transmitted helminth infection. Aim: To assess the helminthic load & efficacy and safety of various antiheliminthics. Methods: A total of 400 patients who met the inclusion criteria were recruited after proper consent. Subjects were divided into Four groups (100 each) randomly & receive different antihelminthic drugs. Cure rate and egg reduction rate was used as a primary outcome measure. Three weeks later two more stool samples were analyzed by two methods 1) Direct Smear method & 2) Concentration method. On follow-up, each group were randomly assigned a single dose of albendazole (single 400 mg dose), mebendazole (100 mg, BD×3 days), pyrantel pamoate (11 mg/kg orally once) and ivermectin (0.2 mg/kg orally once) using a randomization procedure.The data was statistically analysed. Observations: Among 400 patients, 63% were 5-19 years of age, 68% were male, 73.5% were from rural areas, 71% were literate, 62% were in the low income group, 58% reported closed sanitation, 6.75% were having low BMI, 26.25% were having High Absolute Eosinophilic Count before treatment, 77.5% were non-anaemic. 92.5% did not have icterus. In the present study it was seen that the difference among the four drugs was statistically significant as per demographic variables. Significant decrease of worm load after treatment were comparable with each other. However, Presence of Worm across papillae seen after upper GI endoscopy and persistent biliary ascariasis was comparable in all the four drug groups. Overall, the efficacy of anthelmintic drugs was excellent and statistically significant (p<0.001). Conclusion: Albendazole and mebendazole having cure rates of 90% and also reducing the mean egg count by 90%. Also treatment of school children every 4 monthly may be necessary in high endemic areas, like ours. All these drugs which we used in our study are safe and no significant side effects were observed.","PeriodicalId":166206,"journal":{"name":"Oncology, Gastroenterology and Hepatology Reports","volume":"21 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology, Gastroenterology and Hepatology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/OGH.2018.7.1.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Copyright © 2018 Phcog.Net. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license. Cite this article: Kawoosa Z, Javid G, Yattoo GN, Gulzar GM, Sodhi JS, Shah AH, Khan M, Hamid S. To Assess the Efficacy and Safety of Various Anti-heliminthics against Ascariasis Lumbricoides among a Study Population in North India. OGH Reports. 2018;7(1):25-34. ABSTRACT Introduction: More than 24% of the world’s population, are infected with soil-transmitted helminth infection. Aim: To assess the helminthic load & efficacy and safety of various antiheliminthics. Methods: A total of 400 patients who met the inclusion criteria were recruited after proper consent. Subjects were divided into Four groups (100 each) randomly & receive different antihelminthic drugs. Cure rate and egg reduction rate was used as a primary outcome measure. Three weeks later two more stool samples were analyzed by two methods 1) Direct Smear method & 2) Concentration method. On follow-up, each group were randomly assigned a single dose of albendazole (single 400 mg dose), mebendazole (100 mg, BD×3 days), pyrantel pamoate (11 mg/kg orally once) and ivermectin (0.2 mg/kg orally once) using a randomization procedure.The data was statistically analysed. Observations: Among 400 patients, 63% were 5-19 years of age, 68% were male, 73.5% were from rural areas, 71% were literate, 62% were in the low income group, 58% reported closed sanitation, 6.75% were having low BMI, 26.25% were having High Absolute Eosinophilic Count before treatment, 77.5% were non-anaemic. 92.5% did not have icterus. In the present study it was seen that the difference among the four drugs was statistically significant as per demographic variables. Significant decrease of worm load after treatment were comparable with each other. However, Presence of Worm across papillae seen after upper GI endoscopy and persistent biliary ascariasis was comparable in all the four drug groups. Overall, the efficacy of anthelmintic drugs was excellent and statistically significant (p<0.001). Conclusion: Albendazole and mebendazole having cure rates of 90% and also reducing the mean egg count by 90%. Also treatment of school children every 4 monthly may be necessary in high endemic areas, like ours. All these drugs which we used in our study are safe and no significant side effects were observed.
在印度北部研究人群中评估各种抗蛔虫药对类蚓蛔虫的疗效和安全性
版权所有©2018phcog.net这是一篇基于知识共享署名4.0国际许可协议的开放获取文章。引用本文:kaoosa Z, Javid G, Yattoo GN, Gulzar GM, Sodhi JS, Shah AH, Khan M, Hamid S.几种抗蛔虫药对印度蛔虫病的疗效和安全性评价。卫生报告,2018;7(1):25-34。摘要简介:世界上超过24%的人口感染了土壤传播的寄生虫感染。目的:评价各种抗蠕虫剂的抗蠕虫负荷及有效性和安全性。方法:经适当同意后,共招募符合纳入标准的400例患者。受试者随机分为四组(每组100人),分别服用不同的抗虫药物。治愈率和减卵率作为主要结局指标。3周后,再对2份粪便标本进行直接涂片法和浓度法分析。在随访中,每组随机分配单剂量阿苯达唑(单剂量400 mg)、甲苯达唑(100 mg, BD×3天)、帕马酸吡喃酯(11 mg/kg口服一次)和伊维菌素(0.2 mg/kg口服一次)。对数据进行统计学分析。观察:400例患者中,5-19岁占63%,男性占68%,农村占73.5%,识字占71%,低收入占62%,卫生设施封闭占58%,低BMI占6.75%,治疗前嗜酸性粒细胞绝对计数高占26.25%,非贫血占77.5%。92.5%无黄疸。在本研究中,我们发现四种药物在人口学变量上的差异具有统计学意义。处理后蜗杆负荷的显著降低具有可比性。然而,在所有四种药物组中,上消化道内窥镜检查和持续胆道蛔虫病后发现的蠕虫穿过乳头的存在是相似的。总的来说,驱虫药的疗效很好,有统计学意义(p<0.001)。结论:阿苯达唑和甲苯达唑治愈率可达90%,平均卵数可降低90%。在像我国这样的高流行地区,每4个月对学龄儿童进行治疗可能是必要的。我们在研究中使用的所有药物都是安全的,没有观察到明显的副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。